A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In China

NCT01692886 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1674

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumococcal Infection

Interventions

BIOLOGICAL: 7-valent Pneumococcal Conjugate Vaccine
BIOLOGICAL: 13-valent Pnumococcal Conjugate vaccine
BIOLOGICAL: 13-valent Pnumococcal Conjugate vaccine
BIOLOGICAL: 13-valent Pnumococcal Conjugate vaccine

Sponsor

Pfizer